KB425796-A, a novel antifungal antibiotic produced by Paenibacillus sp. 530603

[1]  G. Garrity.  Bergey’s Manual® of Systematic Bacteriology , 2012, Springer New York.

[2]  C. Viscoli,et al.  Current Role of Echinocandins in the Management of Invasive Aspergillosis , 2011, Current infectious disease reports.

[3]  Toshimitsu Kobayashi,et al.  Evaluation of the safety and efficacy of micafungin in Japanese patients with deep mycosis: a post-marketing survey report , 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[4]  T. Patterson,et al.  Overview of antifungal agents. , 2009, Clinics in chest medicine.

[5]  Masami Takeuchi,et al.  Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Hino,et al.  FR220897 and FR220899, Novel Antifungal Lipopeptides from Coleophoma empetri No. 14573 , 2006, The Journal of Antibiotics.

[7]  Seri Intan Mokhtar,et al.  Phylogenetic Analysis of Immunosuppressant FK506-Producing Streptomycete Strains , 2005 .

[8]  S. Kohno,et al.  Micafungin: a therapeutic review , 2004, Expert review of anti-infective therapy.

[9]  O. Cornely,et al.  The first echinocandin: caspofungin , 2002, Mycoses.

[10]  F. Ikeda,et al.  Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus. , 2002, The Journal of antibiotics.

[11]  J. Liu,et al.  1,3-beta-Glucan synthase: a useful target for antifungal drugs. , 2001, Current drug targets. Infectious disorders.

[12]  H. Yamaguchi,et al.  In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens. , 2000, The Journal of antibiotics.

[13]  M. Okuhara,et al.  FR901469, a novel antifungal antibiotic from an unidentified fungus No.11243. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological properties. , 2000, The Journal of antibiotics.

[14]  M. Okuhara,et al.  FR901469, a novel antifungal antibiotic from an unidentified fungus No.11243. II. In vitro and in vivo activities. , 2000, The Journal of antibiotics.

[15]  Koji Kawabata,et al.  In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi , 2000, Antimicrobial Agents and Chemotherapy.

[16]  A. Yamada,et al.  FK463, a novel water-soluble echinocandin lipopeptide: synthesis and antifungal activity. , 1999, The Journal of antibiotics.

[17]  E. Ben-Jacob,et al.  Paenibacillus dendritiformis sp. nov., proposal for a new pattern-forming species and its localization within a phylogenetic cluster. , 1999, International journal of systematic bacteriology.

[18]  J. Wade.  Treatment of fungal and other opportunistic infections in immunocompromised patients. , 1997, Leukemia.

[19]  D. Zeckner,et al.  Semisynthetic chemical modification of the antifungal lipopeptide echinocandin B (ECB): structure-activity studies of the lipophilic and geometric parameters of polyarylated acyl analogs of ECB. , 1995, Journal of medicinal chemistry.

[20]  M. Hansen,et al.  A new sensitive bioassay for precise quantification of interferon activity as measured via the mitochondrial dehydrogenase function in cells (MTT‐method) , 1990, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.